RVTY
Revvity, Inc. · Healthcare · Medical - Diagnostics & Research
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 133 | +9 | 66.02M | $7.35B | +14 | −4 |
| Q1 2026 | 126 | -7 | 72.99M | $6.39B | +4 | −12 |
| Q4 2025 | 133 | 0 | 75.39M | $7.30B | +3 | −2 |
| Q3 2025 | 19 | +1 | 44.69M | $3.92B | +1 | −1 |
| Q2 2025 | 16 | +1 | 42.02M | $4.06B | +3 | −2 |
| Q1 2025 | 12 | -1 | 20.50M | $2.17B | — | −1 |
| Q4 2024 | 13 | 0 | 18.11M | $2.02B | +1 | −1 |
| Q3 2024 | 12 | -1 | 11.86M | $1.51B | +1 | −2 |
| Q2 2024 | 13 | — | 11.86M | $1.24B | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 5.32M | — | $558.17M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 5.32M | — | $558.17M | 0.1% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (pasivo) | 2.84M | — | $296.85M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (pasivo) | 2.84M | — | $296.85M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Norges Bank ✦ (pasivo) | 1.14M | — | $119.56M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | PRIMECAP Management ✦ | 966.75K | — | $101.37M | 0.1% | n/c | 1 | SEC ↗ |
| 7 | Millennium Management ✦ | 661.47K | — | $69.36M | 0.1% | n/c | 1 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 489.61K | — | $51.34M | 0.1% | n/c | 1 | SEC ↗ |
| 9 | Adage Capital Partners ✦ | 218.39K | — | $22.90M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 90.13K | — | $9.45M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 90.13K | — | $9.45M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Gotham Asset Management ✦ | 78.51K | — | $8.23M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | Fisher Asset Management ✦ | 39.09K | — | $4.10M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Wellington Management ✦ | 6.56K | — | $687,987 | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Wellington Management ✦ | 6.56K | — | $687,987 | 0.0% | n/c | 1 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 5.63K | — | $590,364 | 0.0% | n/c | 1 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 5.63K | — | $590,364 | 0.0% | n/c | 1 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 5.63K | — | $590,364 | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Bridgewater Associates ✦ | 2.11K | — | $221,569 | 0.0% | n/c | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 495 tenedores, 115.11M acciones, $7.19B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.